These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15118453)

  • 1. Contamination control in nursing with filtration: part 2: emerging rationale for bedside (final) filtration of prestorage leukocyte-reduced blood products.
    Ortolano GA; Russell RL; Angelbeck JA; Schaffer J; Wenz B
    J Infus Nurs; 2004; 27(3):157-65. PubMed ID: 15118453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA alloimmunization of surgical patients by transfusion with bedside leukoreduced blood components.
    Ohto H; Nomizu T; Kuroda F; Hoshi T; Rokkaku Y
    Fukushima J Med Sci; 2003 Jun; 49(1):45-54. PubMed ID: 14603951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte-reduced blood components: patient benefits and practical applications.
    Higgins VL
    Oncol Nurs Forum; 1996 May; 23(4):659-67. PubMed ID: 8735324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in transfusion therapy.
    Beck SJ
    Clin Lab Sci; 1994; 7(4):225-31. PubMed ID: 10147432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA antigens on leukocyte fragments and plasma proteins: prestorage leukoreduction by filtration.
    Dzik S; Szuflad P; Eaves S
    Vox Sang; 1994; 66(2):104-11. PubMed ID: 8184591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte depletion of cellular blood components.
    Lane TA
    Curr Opin Hematol; 1994 Nov; 1(6):443-51. PubMed ID: 9371321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filtration of platelet concentrates.
    Müller N
    Infusionstherapie; 1991 Jun; 18 Suppl 1():19-23. PubMed ID: 1917059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte reduction in blood component therapy.
    Lane TA; Anderson KC; Goodnough LT; Kurtz S; Moroff G; Pisciotto PT; Sayers M; Silberstein LE
    Ann Intern Med; 1992 Jul; 117(2):151-62. PubMed ID: 1605430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Filtering out the confusion about leukocyte-poor blood components.
    Baranowski L
    J Intraven Nurs; 1991; 14(5):298-306. PubMed ID: 1748913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukoreduction of blood components.
    Dzik WH
    Curr Opin Hematol; 2002 Nov; 9(6):521-6. PubMed ID: 12394176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Filtration of buffy coat free red cell concentrates in additive solution.
    Dietrich G; Dietrich K; Kretschmer V; Eckle R
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):151-6. PubMed ID: 1498559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of two types of leukocyte removal filters on transfusion dependent thalassaemics.
    Jamal R; Mazeni NR; Hussin H
    Malays J Pathol; 2000 Dec; 22(2):79-83. PubMed ID: 16329539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal leukoreduction of cellular and plasma components: process control and performance of the leukoreduction process.
    Masse M
    Transfus Clin Biol; 2001 Jun; 8(3):297-302. PubMed ID: 11499981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual reduction in the immunologic and infectious complications of transfusion by filtration/removal of leukocytes from donor blood soon after collection.
    Rawal BD; Davis RE; Busch MP; Vyas GN
    Transfus Med Rev; 1990 Oct; 4(4 Suppl 1):36-41. PubMed ID: 2134639
    [No Abstract]   [Full Text] [Related]  

  • 15. Benefit of prestorage leukocyte depletion of single-donor platelet concentrates.
    Chalandon Y; Mermillod B; Beris P; Doucet A; Chapuis B; Roux-Lombard P; Dayer JM
    Vox Sang; 1999; 76(1):27-37. PubMed ID: 9933851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical applications of leukocyte filters].
    Bordin JO; Fabron Júnior A
    Rev Assoc Med Bras (1992); 1997; 43(3):205-8. PubMed ID: 9497547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prestorage leukocyte depletion of blood products in a closed system.
    Pietersz RN; Steneker I; Reesink HW
    Transfus Med Rev; 1993 Jan; 7(1):17-24. PubMed ID: 8431656
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on leucocyte depletion of blood components by filtration.
    Pietersz RN; van der Meer PF; Seghatchian MJ
    Transfus Sci; 1998 Dec; 19(4):321-8. PubMed ID: 10351145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leukocyte depletion of blood products and anti-HLA immunization].
    Valla A
    Rev Fr Transfus Hemobiol; 1993 Jun; 36(3):281-91. PubMed ID: 8347251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine.
    Hillyer CD; Josephson CD; Blajchman MA; Vostal JG; Epstein JS; Goodman JL
    Hematology Am Soc Hematol Educ Program; 2003; ():575-89. PubMed ID: 14633800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.